Sentences with phrase «as the manufacturer claims»

If you are concerned that you have been regularly exposed to cross contact from gluten over a period of days then you may find the stool test useful (assuming the test works as the manufacturer claims).

As the manufacturers claim, this is the most «waistline - friendly protein».

As the manufacturer claims, IdealLean BCAAs for Women features several targeted ingredients that help burn fat and act as a metabolism booster.

Focus Factor may not be as effective as its manufacturer claims but it is relatively safe.

As one of the most marketed and highly touted testosterone boosters, it is not clear yet if Tribulus Terrestris is as powerful and effective as manufacturers claim.

The factory data plate is shown above, confirming the engine and chassis numbers as well as the manufacturers claimed peak output of 92 horsepower at 5,600 rpm.

Not as good as manufacturers claim which seem to be the expected, but reasonable for engine and auto box 23 around town 34 on the motorway.

I am re-running some of these tests using different content before I declare this issue closed, but for the time being, test results indicate that neither the ThinkPad Tablet or the Iconia A500 output in 1080p, as each manufacturer claims that they do.

Larger units often do, and it's worth reading reviews and digging around online to see if the fans are as quiet as the manufacturer claims.

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

As a result, some major food manufacturers have preemptively stopped using the term — only to start using similar claims.

That powerful lobby group also claims that earlier Buy American rules tied to President Obama's 2009 stimulus package, delayed «shovel - ready» projects as municipalities conferred with lawyers and manufacturers refrained from bidding on projects because they found it difficult to avoid sourcing their materials from abroad.

BlackBerry's ability to manage inventory and asset risk; BlackBerry's reliance on suppliers of functional components for its products and risks relating to its supply chain; BlackBerry's ability to obtain rights to use software or components supplied by third parties; BlackBerry's ability to successfully maintain and enhance its brand; risks related to government regulations, including regulations relating to encryption technology; BlackBerry's ability to continue to adapt to recent board and management changes and headcount reductions; reliance on strategic alliances with third - party network infrastructure developers, software platform vendors and service platform vendors; BlackBerry's reliance on third - party manufacturers; potential defects and vulnerabilities in BlackBerry's products; risks related to litigation, including litigation claims arising from BlackBerry's practice of providing forward - looking guidance; potential charges relating to the impairment of intangible assets recorded on BlackBerry's balance sheet; risks as a result of actions of activist shareholders; government regulation of wireless spectrum and radio frequencies; risks related to economic and geopolitical conditions; risks associated with acquisitions; foreign exchange risks; and difficulties in forecasting BlackBerry's financial results given the rapid technological changes, evolving industry standards, intense competition and short product life cycles that characterize the wireless communications industry, and the company's previously disclosed review of strategic alternatives.

Many factors could cause BlackBerry's actual results, performance or achievements to differ materially from those expressed or implied by the forward - looking statements, including, without limitation: BlackBerry's ability to enhance its current products and services, or develop new products and services in a timely manner or at competitive prices, including risks related to new product introductions; risks related to BlackBerry's ability to mitigate the impact of the anticipated decline in BlackBerry's infrastructure access fees on its consolidated revenue by developing an integrated services and software offering; intense competition, rapid change and significant strategic alliances within BlackBerry's industry; BlackBerry's reliance on carrier partners and distributors; risks associated with BlackBerry's foreign operations, including risks related to recent political and economic developments in Venezuela and the impact of foreign currency restrictions; risks relating to network disruptions and other business interruptions, including costs, potential liabilities, lost revenues and reputational damage associated with service interruptions; risks related to BlackBerry's ability to implement and to realize the anticipated benefits of its CORE program; BlackBerry's ability to maintain or increase its cash balance; security risks; BlackBerry's ability to attract and retain key personnel; risks related to intellectual property rights; BlackBerry's ability to expand and manage BlackBerry ® World ™; risks related to the collection, storage, transmission, use and disclosure of confidential and personal information; BlackBerry's ability to manage inventory and asset risk; BlackBerry's reliance on suppliers of functional components for its products and risks relating to its supply chain; BlackBerry's ability to obtain rights to use software or components supplied by third parties; BlackBerry's ability to successfully maintain and enhance its brand; risks related to government regulations, including regulations relating to encryption technology; BlackBerry's ability to continue to adapt to recent board and management changes and headcount reductions; reliance on strategic alliances with third - party network infrastructure developers, software platform vendors and service platform vendors; BlackBerry's reliance on third - party manufacturers; potential defects and vulnerabilities in BlackBerry's products; risks related to litigation, including litigation claims arising from BlackBerry's practice of providing forward - looking guidance; potential charges relating to the impairment of intangible assets recorded on BlackBerry's balance sheet; risks as a result of actions of activist shareholders; government regulation of wireless spectrum and radio frequencies; risks related to economic and geopolitical conditions; risks associated with acquisitions; foreign exchange risks; and difficulties in forecasting BlackBerry's financial results given the rapid technological changes, evolving industry standards, intense competition and short product life cycles that characterize the wireless communications industry.

So the claim that Hero is the largest bicycle manufacturer is clearly wrong and in my opinion could be interpreted as misleading investors believing that there is a «deep pocket» Indian investor, whereas in reality, Hery cycles is only a relatively small company selling lots of ultracheap bicycles.

As of August 5, 2014, all manufacturers of FDA - regulated packaged food making a gluten - free claim must comply with the guidelines outlined by the FDA.

If a non-organic product contains corn, soy, canola oil, or even sugar (as a significant amount of sugar is now produced from GMO sugar beets) it may contain GMOs unless the manufacturer makes a specific claim that their product is GMO free.

With the focus moving towards more regulation, manufacturers will need to be armed with as much information about the nutritional and sensory profile of their product as possible if they want to make a «five a day» or even «seven a day» claim.

Dark chocolate risks tumbling from its «good for you» confectionery pedestal, as a UK medical journal claims that many manufacturers in fact remove the heart healthy element - the flavanols.

Date paste, date juice concentrate (date syrup) and chopped dates, which are the most common date ingredients in final products, retain some of these benefits and hence suit manufacturers» needs as well, contributing to clean label claims and reducing sugar.

Happy as a Hog With a storied legacy in North Carolina, Stevens Sausage can lay claim as a premier manufacturer of pork products in the Southeast.

Amelia's Bay newest white paper, «Transform Your Tea: Balancing the Perfect Brew,» gives beverage manufacturers a thorough understanding of how brewed tea characteristics and label claims both factor into the success of their RTD iced tea products - especially significant since tea's popularity is growing as quickly as its list of health benefits.

Lists of so - called «no - no» components direct manufacturers toward ingredients, formulations, and front - of - pack label claims to appeal to three consumer expectations: no food additives or synthetics; ingredients listed with commonly used names, without chemical or artificial implications (think «vitamin E» instead of «tocopherol» or «tocotrienol»); and minimal processing using traditional techniques that are not perceived as artificial.

It allows manufacturers to make the «natural» label claim and serves as a replacement for vanilla bean or for addressing the need for more natural ingredients in food — at a fraction of cost.

Food manufacturers can look to the past as a dependable source of inspiration, such as «ancient» product claims, including ancient grains.

This then, is not the case of a manufacturer, after the expiration of a patent, availing himself of the right to make the identical article patented and claiming the right to identify it by the name given to it by the inventor, or acquired by it as identifying the patented article.

The name had been used by Edmund McIlhenny and his successors, since 1868, and the five or six other manufacturers who had used it during the preceding few years had been notified of the McIlhenny claim to its exclusive use as a trade - mark.

«The rulings just referred to establish the proposition that the fact that a word or expression has a geographical meaning does not prevent its appropriation as a trade - mark or as the designation of a manufacturer's or dealer's product, when it is so used as not to have a geographical or descriptive signification, nor make legally impossible the assertion in good faith of a claim of exclusive right to use such word or expression for a non-geographical and non-descriptive purpose, even though such use may result or have resulted in its acquiring a new meaning or new meanings separate and distinct from the one it had before.»

Salt of the Earth claimed that formulating meat substitutes using its Mediterranean Umami ingredient enables food manufacturers to meet hot demands such as clean label, plant - based, and rich in umami flavor, with a significant reduction of salt.

For years, it seems, MomsTEAM has been getting e-mails from mouth guard manufacturers touting their products as reducing the risk of concussion, despite the lack of any peer - reviewed scientific studies to support their claims.

I recognize that NOCSAE's decision may have some technical merit; and that it may be to some degree be necessary to protect the integrity of its helmet standard by weeding out what one football helmet representative characterized in an email to me as «snake oil salesmen» marketing supplemental padding products that, despite their overblown claims, likely do little if anything to reduce, much less prevent, concussions, and may, at least in theory, compromise the ability of football helmets to protect players as the manufacturers intended.

Even so - called «SIDS - safe» products, such as sleep positioners and alternative bumpers, do not currently fall subject to FDA regulation, leaving manufacturers free to make unsubstantiated safety claims about their products.

Marketed most commonly as a healthy, natural way for the elderly to ease joint pain, or for you to ease your baby's teething pain, manufacturers also claim that Baltic Amber can...

Worn by the baby, manufacturers claim that certified 100 % Baltic Amber contains succinic acid, which acts as an anti-inflammatory agent for fussy babies.

One issue is Mapa Spontex, the manufacturer of the NUK brand, markets its First Choice teat with the claim it is «Clinically Proven» for «Combined Feeding», and encourages breastfeeding mothers to introduce feeding bottles from as early as one week of age.

Manufacturers sometimes claim that their digital video monitors are safe, but they're not as secure as they could be, Keromytis said.

As for video monitors, the best defense is to buy one that uses Wi - Fi, he said, and never rely on a manufacturer's claim that it is secure.

So, three decades on from the boycott's inception, I have come to Bangladesh to find out whether Nestlé has - as it claims - changed its behaviour, and is now a reformed organisation, or whether the campaigners have been right to keep up the pressure all these years, not just on Nestlé but on other formula manufacturers too.

Not claiming expertise in the matter I double checked my source materials and reference papers on brick manufacturers but could find no Walsh brickyard in the literature as existing at Glasco, Town of Saugerties.

The U.S. Food and Drug Administration regulates all dietary supplements as food products under the 1994 Dietary Supplement Health and Education Act, which says that the manufacturers are only responsible for making sure a supplement is safe and meets efficacy claims.

Manufacturers have to make sure dietary supplements are safe, but they don't have to prove the claimed benefits, as drug manuManufacturers have to make sure dietary supplements are safe, but they don't have to prove the claimed benefits, as drug manufacturersmanufacturers do.

These allow manufacturers that make very low emission vehicles, such as electric vehicles, to claim extra credits for them, so they can continue to produce more heavily polluting vehicles as well.

A 2006 analysis published in the American Journal of Psychiatry found that 90 percent of manufacturer - sponsored studies of antipsychotic drugs led to claims that the study drug was as good as, or superior to, every other drug in its class.

The manufacturer claims a 28 % better improvement in the strength as compared with the other creatine supplements in the market.

I like the fact that they don't claim the higher number, as many other manufacturers do.

The manufacturer of Phen375 claims that Phen375 works as a powerful appetite suppressant which controls your appetite and reduces cravings for food.

Manufacturers of this tape, such as Rocktape and Spidertape, claim that unlike traditional athletic tape, kinesiotape increases fluid drainage through special channels formed in the skin, and may alter joint motion through the elastic tension applied to the tape (3).

Claims that plant - based diets contain plenty of the calcium we need for bone building and other functions are seriously undercut when one considers the phytate content and modern processing methods.30 In products naturally low in calcium such as soy milk, manufacturers like to boast about added calcium while remaining mum about phytates.

Beware of manufacturer claims you see on boxes, as none are backed by credible research.

But the science behind the blanket's claims is scarce — as STAT found by reviewing the studies the manufacturer cites as evidence for its claims.